SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-180622
Filing Date
2015-05-11
Accepted
2015-05-11 07:17:00
Documents
4
Period of Report
2015-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d922803d8k.htm 8-K 15367
2 EX-99.1 d922803dex991.htm EX-99.1 59010
3 GRAPHIC g922803ex99_1footer.jpg GRAPHIC 4057
4 GRAPHIC g922803ex99_1logo.jpg GRAPHIC 11932
  Complete submission text file 0001193125-15-180622.txt   97862
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 15848855
SIC: 2834 Pharmaceutical Preparations